Health ❯ Healthcare ❯ Clinical Trials

Patient Outcomes

Survival Rates Quality of Life Remission Rates Mortality Rates Gender Differences Long-term Remission Risk Stratification Therapeutic Advances Recurrence Rates Efficacy and Safety Therapeutic Strategies Biomarkers Treatment Response Drug Efficacy Precision Medicine Treatment Resistance Treatment Efficacy Visual Acuity Improvement Event-Free Survival Personalized Medicine Disease Progression Cognitive Function Remission Cases Medical Innovations IVF Success Rates Transplant Viability Patient-Centered Care Survival Analysis PREOPANC1 Study HbA1c Reduction Symptom Management DFCI 16-001 Trial Cancer Recovery Weight Loss Effects BCG-unresponsive NMIBC Long-term Efficacy Precision Oncology Vision Restoration Trials Orig-AMI 4 Trial Disease-Modifying Activity Innovative Therapies Leukemia Treatments Progression-Free Survival (PFS) Adverse Events Non-Invasive Markers Weight Management Weight Loss Maintenance VOLT-AF IDE Study Platelet Response Functional Outcomes Long-term Survival Efficacy Research Studies AI in Clinical Trials Organ Donation Disease Management Gene Therapy Results Long-term Recovery Erectile Function Recovery Genetic Profiling Recurrence Prediction Weight Loss Medications Cancer Treatment Efficacy Long-term Health Improvements Imaging Techniques Long-term Care Hearing Restoration Progression-Free Survival Neurodevelopmental Delay Ischemic Events

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

Researchers plan prospective, prediagnostic studies to test screening use in high-risk groups.

First Pivotal Trial Finds Cooled-Laser Prostate Therapy Effective at 3 Months With Low Morbidity

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

Sacituzumab Govitecan Gains First-Line Ground in TNBC, Falls Short in Early HR+/HER2− Use

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering

Study at ASH Finds One-Third of Families Treating Pediatric ALL Face Severe Financial Strain

NICE Backs Obe-cel for Adults With Aggressive Leukaemia as NHS Fast-Tracks Rollout

Padcev–Keytruda Cuts Recurrence and Death Risk in Cisplatin-Ineligible Muscle-Invasive Bladder Cancer

NEJM Study Finds 95% Long-Term Success for ADA-SCID Gene Therapy

TORPEdO Phase III Finds No One-Year Advantage for Proton Therapy Over IMRT in Oropharyngeal Cancer

Early ctDNA Test Flags Which LS-SCLC Patients Benefit From Consolidation Immunotherapy

ESC Trials Recast Antiplatelet Strategies After PCI and CABG

Pilot RCT Signals Faster IVF Conception for Women 35–42 Using PGT-A

First Targeted Treatment Eliminates Rare T-Cell Lymphoma After CAR T

Danish Real-World Study Finds PSMA PET/CT Before Salvage Radiotherapy Boosts Prostate Cancer Survival